Walmart shares slide as U.S. sales hit by falling drug prices
The supermarket chain reported comparable U.S. sales growth of 2.6% in its second-quarter earnings, its lowest in over six years.
This is a summary aggregated from MarketWatch. Read the complete article on the original site:
Read full article at MarketWatch
